Blood and plasma donors during the COVID-19 pandemic: arguments against financial stimulation

Area of Science:

• Medical Ethics
• Public Health Policy
• Hematology

Background:

• The COVID-19 pandemic created an urgent need for blood and convalescent plasma donations.
• Existing donor recruitment strategies required modification to meet increased demand.
• Financial incentives are ethically prohibited for blood donation.

Purpose of the Study:

• To ethically analyze the consequences of shifting focus from voluntary unpaid blood donors to paid donors or blood sellers.
• To evaluate the potential impact on the integrity of the blood and plasma donor system.

Main Methods:

• Ethical framework analysis
• Review of existing literature on donor motivation and incentives
• Comparative analysis of voluntary vs. paid donation systems

Main Results:

• Shifting focus to paid donors may undermine altruistic motivations central to voluntary systems.
• Potential for exploitation and coercion in paid donation models.
• Risk of compromising the safety and availability of blood products.

Conclusions:

• Maintaining a robust voluntary, unpaid blood donor system is ethically paramount.
• Financial incentives pose significant ethical risks and are not a viable solution for increasing donations.
• Policy discussions should prioritize ethical recruitment strategies that preserve the integrity of blood donation.